Robert F. Kennedy Jr. Reverses FDA Peptide Ban: What It Means for Public Health
Health Secretary Robert F. Kennedy Jr. has reversed the FDA’s 2023 ban on compounding certain peptides, including BPC-157 and GHK-Cu. Critics warn thi...
Health Secretary Robert F. Kennedy Jr. has reversed the FDA’s 2023 ban on compounding certain peptides, including BPC-157 and GHK-Cu. Critics warn thi...
Robert F. Kennedy Jr.'s campaign to ease federal restrictions on peptides could trigger a massive wellness trend, benefiting telehealth firms, compoun...